Profile | GDS4284 / 204001_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2686.28 | 87 |
GSM687648 | Patient 402 control | 2462.04 | 86 |
GSM687653 | Patient 403 control | 2350.43 | 86 |
GSM687658 | Patient 404 control | 1942.1 | 83 |
GSM687663 | Patient 411 control | 1923.49 | 83 |
GSM687668 | Patient 422 control | 3125.3 | 89 |
GSM687673 | Patient 424 control | 1491.43 | 80 |
GSM687678 | Patient 425 control | 1455.4 | 79 |
GSM687683 | Patient 427 control | 2448.61 | 86 |
GSM687688 | Patient 428 control | 2539.22 | 87 |
GSM687695 | Patient 441 control | 1006.62 | 75 |
GSM687699 | Patient 443 control | 1776.82 | 83 |
GSM687704 | Patient 444 control | 1372.66 | 79 |
GSM687707 | Patient 448 control | 986.19 | 74 |
GSM687712 | Patient 449 control | 2449.74 | 86 |
GSM687719 | Patient 450 control | 1689.65 | 82 |
GSM687724 | Patient 451 control | 1393.24 | 79 |
GSM687728 | Patient 452 control | 1821.81 | 83 |
GSM687646 | Patient 401 treated 24h | 2585.81 | 87 |
GSM687649 | Patient 402 treated 24h | 2798.22 | 88 |
GSM687665 | Patient 411 treated 24h | 1769.06 | 82 |
GSM687651 | Patient 402 treated 4 weeks | 2680.48 | 88 |
GSM687667 | Patient 411 treated 4 weeks | 2238.3 | 85 |
GSM687670 | Patient 422 treated 24h | 2377.92 | 86 |
GSM687671 | Patient 422 treated 4 weeks | 2723.43 | 87 |
GSM687654 | Patient 403 treated 24h | 2152.89 | 85 |
GSM687675 | Patient 424 treated 24h | 1947.04 | 84 |
GSM687685 | Patient 427 treated 24h | 2744.62 | 88 |
GSM687656 | Patient 403 treated 4 weeks | 2056.17 | 84 |
GSM687677 | Patient 424 treated 4 weeks | 1319.54 | 78 |
GSM687687 | Patient 427 treated 4 weeks | 2543.08 | 87 |
GSM687692 | Patient 428 treated 4h | 2404.49 | 86 |
GSM687716 | Patient 449 treated 4h | 2174.15 | 85 |
GSM687722 | Patient 450 treated 4h | 1816.49 | 83 |
GSM687680 | Patient 425 treated 24h | 1822.24 | 82 |
GSM687690 | Patient 428 treated 24h | 2256.61 | 85 |
GSM687700 | Patient 443 treated 24h | 1176.63 | 76 |
GSM687705 | Patient 444 treated 24h | 1507.23 | 80 |
GSM687714 | Patient 449 treated 24h | 2720.57 | 88 |
GSM687721 | Patient 450 treated 24h | 1553.13 | 81 |
GSM687682 | Patient 425 treated 4 weeks | 1496.27 | 80 |
GSM687694 | Patient 428 treated 4 weeks | 1870.24 | 82 |
GSM687702 | Patient 443 treated 4 weeks | 1855.02 | 83 |
GSM687718 | Patient 449 treated 4 weeks | 2222.47 | 85 |
GSM687723 | Patient 450 treated 4 weeks | 1759.49 | 82 |
GSM687661 | Patient 404 treated 4h | 1841.65 | 83 |
GSM687710 | Patient 448 treated 4h | 1256.09 | 78 |
GSM687726 | Patient 451 treated 4h | 1105.65 | 75 |
GSM687730 | Patient 452 treated 4h | 1267.29 | 78 |
GSM687660 | Patient 404 treated 24h | 926.735 | 75 |
GSM687697 | Patient 441 treated 24h | 1068.53 | 76 |
GSM687709 | Patient 448 treated 24h | 1306.2 | 78 |
GSM687725 | Patient 451 treated 24h | 1395.7 | 79 |
GSM687729 | Patient 452 treated 24h | 1089.44 | 77 |
GSM687727 | Patient 451 treated 4 weeks | 874.18 | 72 |
GSM687731 | Patient 452 treated 4 weeks | 1790.86 | 82 |